Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure - Wikidata - wikimedia - TriplyDB

Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure

Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure

http://www.wikidata.org/entity/Q36103534

about

Skeletal changes through the lifespan--from growth to senescence Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.Parathyroid hormone therapy for hypoparathyroidism Use of parathyroid hormone in hypoparathyroidism.PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization.Noninvasive Assessment of Skeletal Microstructure and Estimated Bone Strength in Hypoparathyroidism.The effect of PTH(1-84) on quality of life in hypoparathyroidism.Short-Term PTH(1-34) Therapy in Children to Correct Severe Hypocalcemia and Hyperphosphatemia due to Hypoparathyroidism: Two Case Studies PTH replacement therapy of hypoparathyroidism.Causes, mechanisms and management of paediatric osteoporosis.Bone disease in hypoparathyroidism.Bone imaging in hypoparathyroidism.Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).Efficacy of Teriparatide in Patients with Hypoparathyroidism: A Prospective, Open-label Study Repurposing a novel parathyroid hormone (PTH) analog to treat hypoparathyroidism.Bone Status Among Patients With Nonsurgical Hypoparathyroidism, Autosomal Dominant Hypocalcaemia, and Pseudohypoparathyroidism: A Cohort Study.Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology.

P2860

Q26999948-21CA9F02-F619-4213-A659-125F21C6EF5B Q34149279-4BFF387A-DDC0-4C50-938A-D3C73BC09BA7 Q35014795-AD6B4CE7-1B23-4212-BE3C-C80B85B7A923 Q35043115-0EA4D076-0B1C-4D7B-87D1-159B2BCFAE81 Q35100381-8E9D0C06-704B-4CDC-BE68-45154579957C Q36795949-0ED37F38-0737-44B4-A64C-5FCAA7422251 Q36800736-A5A849FA-E2A5-4B5B-85AE-815D0FD90C7F Q36885818-290FA205-A596-46DA-9795-5BE5E09E4609 Q37443203-BD74CA12-42D1-4361-977A-EF55262D8426 Q38062849-4AE48EC5-639E-4FF3-9388-9BDB26485A8A Q38099517-7292E1F2-8278-48D5-A556-F381EC1DCAE6 Q38244174-DFB9BC37-F0A5-4768-ABA9-C3CBF6F4AB5D Q38941679-6E674E69-1612-4FD0-8EB3-0F2F6893B184 Q40946883-C5B0E580-E190-4BAC-BB34-D44F6FF8168E Q42161805-A352D7B5-03CA-4EA4-814A-A45A786B0232 Q42689961-903859FF-6901-43D0-BB79-8AFAA9BD64E7 Q47683848-E597E413-9DB0-4986-9113-5F151C648665 Q48160184-81620CA4-3715-434F-BCC8-63A6061BBEFD

P2860

Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure

http://www.wikidata.org/entity/Q36103534

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Daily parathyroid hormone 1-34 ...... in bone turnover and structure

@ast

Daily parathyroid hormone 1-34 ...... in bone turnover and structure

@en

type

label

Daily parathyroid hormone 1-34 ...... in bone turnover and structure

@ast

Daily parathyroid hormone 1-34 ...... in bone turnover and structure

@en

prefLabel

Daily parathyroid hormone 1-34 ...... in bone turnover and structure

@ast

Daily parathyroid hormone 1-34 ...... in bone turnover and structure

@en

P1433

Q36103534-570B15AD-F4CF-4E93-B4AD-BC155848A979

P1476

Q36103534-E883DEEE-7FE4-49CD-A2BB-2FCF5AD5603D

P2093

Q36103534-1CA998D9-6118-4CCF-9BA8-CC8F58248433

Q36103534-23FF50CE-B20A-44FF-986F-FE7F9208A7EA

Q36103534-305517CD-F8ED-45CF-B638-1AB2607700D6

Q36103534-330D53C2-C332-4F49-92D3-F05949BC3252

Q36103534-3FB8D8A2-4C4A-4B55-8E3E-B8260812B4EC

Q36103534-62E795EF-7629-4E83-9181-F8FA0B15CDAB

Q36103534-AB27AF51-5228-41A7-AE1B-AE58BF532CEB

Q36103534-AC8D5CF5-045A-4F9A-B046-036ADD9EEEDA

Q36103534-D4B5B5E7-D725-4ACE-A868-389993DB9F65

Q36103534-ED97F3AA-0E39-472F-B222-B32A40B4F206

P2860

Q36103534-0010B1BF-A672-46DF-A5B7-C3C05E3EC593

Q36103534-1E5642A0-71A9-466D-A80A-C702C1886E08

Q36103534-294CBF98-19BA-4D7D-BF0D-C8681B38B91C

Q36103534-2E75A8C3-16FE-404A-BAB1-BDECBE78B394

Q36103534-30AD0B46-4542-4C85-BC35-8354E1A75A21

Q36103534-41A62558-FFD9-491E-A27D-F98A71FD4CE2

Q36103534-47CDD7F7-8EBA-41D8-8ECB-F6361D3B43AB

Q36103534-5BE26073-2740-4012-8040-EA0DA10030FB

Q36103534-810E6EAA-9B64-413C-8890-0E86EB9CBA57

Q36103534-A8CBA559-E2EE-4822-8DFC-A32AA8C558F2

P304

Q36103534-E28E6F5C-2BC0-41E8-AD82-642F5FF65E3F

P31

Q36103534-DC32B08C-D153-4830-91A4-C50DCED56977

P356

Q36103534-8D355AFF-AB21-4756-BB59-25E2BD28A38B

P433

Q36103534-F4AD84F9-B1B7-4667-838C-297E827EF23B

P478

Q36103534-8B046971-A173-4482-961B-E17072C77769

P577

Q36103534-2EBBCD54-4B4F-4AFF-AA7C-7E306AAE6CE2

P5875

Q36103534-ACB0271A-1ADD-492B-A1FF-37CC6D7E541B

P698

Q36103534-EFC24EDF-0753-4886-9E1E-7E5078DD6562

P932

Q36103534-3476EE2F-255E-472D-93E0-022183E1ABB9

P356

P1433

Journal of Bone and Mineral Research

P1476

Daily parathyroid hormone 1-34 ...... in bone turnover and structure

@en

P2093

Beth A Brillante

http://www.w3.org/2001/XMLSchema#string

David W Dempster

http://www.w3.org/2001/XMLSchema#string

Hua Zhou

http://www.w3.org/2001/XMLSchema#string

Jaime S Brahim

http://www.w3.org/2001/XMLSchema#string

James C Reynolds

http://www.w3.org/2001/XMLSchema#string

Marilyn H Kelly

http://www.w3.org/2001/XMLSchema#string

Michael T Collins

http://www.w3.org/2001/XMLSchema#string

Nisan Bhattacharyya

http://www.w3.org/2001/XMLSchema#string

Panagiota Andreopoulou

http://www.w3.org/2001/XMLSchema#string

Rachel I Gafni

http://www.w3.org/2001/XMLSchema#string

P2860

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study.

Normative data for iliac bone histomorphometry in growing children.

The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race.

PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.

Therapy of hypoparathyroidism with intact parathyroid hormone.

Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females.

Changes in quantitative bone histomorphometry in aging healthy men.

Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism

P304

1811-1820

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBMR.1627

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223973916

http://www.w3.org/2001/XMLSchema#string

P698

22492501

http://www.w3.org/2001/XMLSchema#string

P932

3399961

http://www.w3.org/2001/XMLSchema#string